Polysome-enriched transcripts identified as increasing in megakaryocytes during proplatelet formation by polysome profiling
| Proteins that correspond to isolated and sequenced mRNA transcripts (protein symbol) . | Round MK (polysome) . | Proplt MK (polysome) . | Ratio (proplt/round) . |
|---|---|---|---|
| Myristoylated alanine-rich C-kinase substrate (MARCKS) | 4.33 | 24.58 | 5.68 |
| Tubulin, β 2B class IIb (TUBB2B) | 33.60 | 139.47 | 4.15 |
| BCL2-like 11 (BCL2l11) | 17.54 | 84.12 | 4.80 |
| BCL2 binding component 3 (BBC3) | 105.51 | 504.99 | 4.97 |
| Kruppel-like factor 10 (KLF10) | 4.99 | 24.33 | 4.87 |
| Interleukin 15 (IL15) | 13.12 | 72.22 | 5.50 |
| Vascular endothelial growth factor C (VEGFC) | 5.98 | 35.51 | 5.93 |
| Chemokine (C-C motif) ligand 5/RANTES (CCL5) | 4.40 | 88.57 | 20.12 |
| Active BCR-related (ABR) | 3.69 | 19.46 | 5.27 |
| Histone cluster 1, H4h (HIST1H4H) | 16.21 | 155.65 | 9.60 |
| Growth arrest and DNA-damage-inducible (GADD45B) | 13.20 | 197.18 | 14.93 |
| Proteins that correspond to isolated and sequenced mRNA transcripts (protein symbol) . | Round MK (polysome) . | Proplt MK (polysome) . | Ratio (proplt/round) . |
|---|---|---|---|
| Myristoylated alanine-rich C-kinase substrate (MARCKS) | 4.33 | 24.58 | 5.68 |
| Tubulin, β 2B class IIb (TUBB2B) | 33.60 | 139.47 | 4.15 |
| BCL2-like 11 (BCL2l11) | 17.54 | 84.12 | 4.80 |
| BCL2 binding component 3 (BBC3) | 105.51 | 504.99 | 4.97 |
| Kruppel-like factor 10 (KLF10) | 4.99 | 24.33 | 4.87 |
| Interleukin 15 (IL15) | 13.12 | 72.22 | 5.50 |
| Vascular endothelial growth factor C (VEGFC) | 5.98 | 35.51 | 5.93 |
| Chemokine (C-C motif) ligand 5/RANTES (CCL5) | 4.40 | 88.57 | 20.12 |
| Active BCR-related (ABR) | 3.69 | 19.46 | 5.27 |
| Histone cluster 1, H4h (HIST1H4H) | 16.21 | 155.65 | 9.60 |
| Growth arrest and DNA-damage-inducible (GADD45B) | 13.20 | 197.18 | 14.93 |